Astellas Venture Management

Astellas Venture Management

Astellas Venture Management

Follow us
Alexa global traffic share
Latest investments Show all
$15,000,000
Venture capital (Series A)
Twentyeight-Seven Therapeutics
$38,600,000
Venture capital (Series C)
Effector Therapeutics
Team Size
1–10
Employees
Past year's investments

Astellas Venture Management participated in fewer than 3 rounds over the past year

Latest rounds
  • Twentyeight-Seven Therapeutics: Venture capital (Series A) ($15M)
  • Effector Therapeutics: Venture capital (Series C) ($38.6M)
  • Oncorus: Venture capital (Series A) (£4M)